Skip to main content

tenofovir disoproxil

J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AF - Nucleoside And Nucleotide Reverse Transcriptase Inhibitors -> J05AF07 - Tenofovir Disoproxil
Administration category: Free Medicine group: antiviral Brand name: Viread

Standard dosages

≥ 18 years
Weight ROA Load Dosage
ROA:
po
Load:
-
Dosage:
245mg 1 dd

Kidney function

Notes GFR general:

Bij nierfunctiestoornissen: gebruik van granules heeft de voorkeur boven gebruik van de tablet.

Granules, onder controle van de tenofovirconcentratie:

kreatinineklaring 30-50 ml/min: 132 mg 1x per dag;

kreatinineklaring 20-30 ml/min: 65 mg 1x per dag;

kreatinineklaring 10-20 ml/min: 33 mg 1x per dag.

Tablet, onder controle van de tenofovirconcentratie:

kreatinineklaring 30-50 ml/min: 245 mg 1x elke 2 dagen;

kreatinineklaring 10-30 ml/min: 245 mg 1x elke 3-4 dagen.

Renal elimination: 70-80%
Dosage: dependent on kidney function

Renal function-replacement therapy

CAPD: gebruik vermijden

Hemo dialysis: dialized - 16,5 mg na elke dialysesessie, onder controle van de tenofovirspiegel

CAV / VVHD: 33 mg 1x per dag, onder controle van de tenofovirspiegel

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.
Metadata

Swab vid: M-2041.4
Updated: 03/26/2024 - 17:19
Status: Published

External links
Menu position